Legal Protection of Biotechnological Inventions

Protection for biotechnology inventions in the United States in the 1980s is the advent of the relation between science and wealth in this field, and in a short time large corporations were established and huge private funds were raised. Contrarily, some European countries, which refused to provide the necessary support due to the prevalence of withholding considerations and widespread biotechnology phobia, lagged far behind. Biotechnology research and development is expensive, and biotechnology investors and researchers are heavily dependent on the protection that can compensate for the costs. The best known way to achieve this is a patent system that emphasizes secure commercialization. Currently, due to weak policy-making and action in the public and private sectors, there are major problems with legal protection in this area in the country. This book tries to critically and reasonably examine the legal aspects of supporting biotechnology innovations in Iran, considering the latest legal sources and achievements, to address the gaps and ambiguities in the current protection system.